APA (7th ed.) Citation

Kral, J., Benes, M., Lanska, V., Macinga, P., Hujova, A., Jarosova, J., . . . Hucl, T. (2023). Su1911 LONG TERM RESULTS OF ENDBARRIER® IN TREATMENT OF OBESITY AND TYPE 2 DIABETES. Gastroenterology (New York, N.Y. 1943), 164(6), S-710-S-711. https://doi.org/10.1016/S0016-5085(23)02651-3

Chicago Style (17th ed.) Citation

Kral, Jan, Marek Benes, Vera Lanska, Peter Macinga, Alzbeta Hujova, Jana Jarosova, Pavel Drastich, Julius Spicak, and Tomas Hucl. "Su1911 LONG TERM RESULTS OF ENDBARRIER® IN TREATMENT OF OBESITY AND TYPE 2 DIABETES." Gastroenterology (New York, N.Y. 1943) 164, no. 6 (2023): S-710-S-711. https://doi.org/10.1016/S0016-5085(23)02651-3.

MLA (9th ed.) Citation

Kral, Jan, et al. "Su1911 LONG TERM RESULTS OF ENDBARRIER® IN TREATMENT OF OBESITY AND TYPE 2 DIABETES." Gastroenterology (New York, N.Y. 1943), vol. 164, no. 6, 2023, pp. S-710-S-711, https://doi.org/10.1016/S0016-5085(23)02651-3.